)
Visual
earnings real time
Amphastar Pharmaceuticals (AMPH) investor relations material
Amphastar Pharmaceuticals Piper Sandler 37th Annual Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Piper Sandler 37th Annual Healthcare Conference summary3 Dec, 2025
Strategic Direction and Pipeline Evolution
Targeting 50% proprietary products in the pipeline by 2026, shifting from generics to more complex and proprietary assets, with 35% biosimilar focus.
Continued commitment to select generics, but focus is on developing and commercializing proprietary and in-licensed products.
Recent in-licensing of three peptide assets from Anji Biopharmaceuticals, all in preclinical stages, with updates expected at IND stage; exclusive license agreement includes up to $453 million in potential payments and royalties.
R&D spend is increasing to support proprietary development, with $351 million invested over five years and potential for licensing or partnerships to manage costs.
Operates a fully integrated model covering R&D, manufacturing, and distribution, enabling control over quality and compliance throughout the product lifecycle.
Product Launches and Growth Drivers
AMP-007 is expected to be a first-to-market generic with potential 180-day exclusivity and is seen as the biggest growth driver for 2026.
Teriparatide generic (AMP-015) launch anticipated in 1H 2026, expected to provide incremental growth.
Insulin aspart biosimilar and a GLP-1 generic (AMP-018) are targeted for 2027 launches, with insulin aspart seen as a larger opportunity.
Iron sucrose generic (AMP-002) recently launched, manufactured in the U.S., with higher margins than average generics.
Key products include BAQSIMI® (intranasal glucagon), Primatene MIST® (OTC asthma inhaler), and a comprehensive diabetes portfolio.
Baqsimi and Commercial Strategy
Baqsimi holds nearly 60% of the ready-to-use glucagon market, with significant room for growth as only 12% of insulin users currently fill glucagon scripts.
Peak sales for Baqsimi projected at $250M–$275M if script penetration reaches 15–16%; acquisition expands international reach to 26 countries.
Expanded salesforce and co-promotion agreement with Mankind expected to drive further growth.
High payer coverage and stable gross-to-net; patent protection extends to 2036–2039, with device exclusivity further delaying generic entry.
Proprietary pipeline funding strategy
AMP-007 market opportunity and exclusivity
Baqsimi commercial strategy and leverage
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Amphastar Pharmaceuticals earnings date
Q4 202527 Feb, 2026
Next Amphastar Pharmaceuticals earnings date
Q4 202527 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Amphastar Pharmaceuticals Inc. is a specialty pharmaceutical company engaged in the development, manufacture, and marketing of generic and proprietary injectable, inhalation, and intranasal products. The company focuses on producing pharmaceuticals for hospital, emergency, and clinical use, including treatments for respiratory conditions, diabetes, and pain management. Amphastar operates manufacturing and research facilities to support its product portfolio and pipeline development. Amphastar Pharmaceuticals Inc. is headquartered in Rancho Cucamonga, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage